Clinical Performance Evaluation of T-TAS®01 HD Chip
Sponsor: Fujimori Kogyo Co., Ltd.
This observational or N/A phase trial investigates Thrombocytopenia and is currently completed. Fujimori Kogyo Co., Ltd. leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Aug 2025 — Present [monthly]
Completed
Status: Suspended → Completed
-
Apr 2025 — Aug 2025 [monthly]
Suspended
-
Dec 2024 — Apr 2025 [monthly]
Suspended
Status: Recruiting → Suspended
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
-
Nov 2023 — Jan 2024 [monthly]
Recruiting
First recorded
Sep 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fujimori Kogyo Co., Ltd.
- Hikari Dx, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .